文献速递青光眼

原发性开角型青光眼遗传风险评分与诊断年龄提前的关联

Association of a Primary Open-Angle Glaucoma Genetic Risk Score With Earlier Age at Diagnosis.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

这项横断面研究纳入GLAUGEN和NEIGHBOR两个队列的原发性开角型青光眼(POAG)患者及对照,用12个POAG相关变异构建遗传风险评分(GRS)。结果显示GRS每升高1分与诊断年龄提前0.36年相关,最高5%GRS者平均比最低5%者早诊断5.2年。作者认为GRS可能有助于识别早发风险患者。

要点

  • GRS每升高1分,POAG诊断年龄平均提前0.36年(β=-0.36,95%CI -0.56至-0.16,P=4.0×10-4)。
  • GRS最高5%者平均诊断年龄比最低5%者早5.2年(61.4岁 vs 66.6岁,P=5.0×10-4)。
  • 病例对照分析中GRS与POAG风险强相关(每1分OR=1.24,95%CI 1.21-1.27,P=3.4×10-66)。

核心结论

  • 较高的POAG风险等位基因负荷与较早年青光眼诊断年龄相关。
  • 平均而言,GRS最高的POAG患者诊断年龄早5.2年。
  • 作者认为包含POAG相关遗传变异的GRS可能有助于识别早发风险患者,影响筛查和治疗策略。

研究设计与样本

  • 横断面研究,纳入GLAUGEN研究和NEIGHBOR研究的POAG患者及对照。
  • GLAUGEN研究包括976例POAG患者和1140例对照。
  • NEIGHBOR研究包括2132例POAG患者和2290例对照。
  • 所有研究参与者均为欧洲白人。
  • 使用12个已知与POAG相关的变异构建GRS,病例对照集中风险等位基因对齐。

主要发现

  • GLAUGEN队列POAG患者平均(SD)诊断年龄为63.6(9.8)岁,NEIGHBOR队列为66.0(13.7)岁。
  • GLAUGEN队列对照平均(SD)入组年龄为65.5(9.2)岁,NEIGHBOR队列为68.9(11.4)岁。
  • 病例对照分析中GRS与POAG风险强相关(评分每增加1分OR=1.24,95%CI 1.21-1.27,P=3.4×10-66)。
  • 病例仅分析中GRS每升高1个单位与诊断年龄提前0.36年相关(β=-0.36,95%CI -0.56至-0.16,P=4.0×10-4)。
  • GRS最高5%者平均(SD)诊断年龄比最低5%者早5.2(12.8)年(61.4[12.7]岁 vs 66.6[12.9]岁,P=5.0×10-4)。

关键数值与推荐

  • GRS由12个与POAG相关的单核苷酸多态性变异构成。
  • 病例对照分析中每1分GRS增加的OR=1.24(95%CI 1.21-1.27,P=3.4×10-66)。
  • 病例仅分析中GRS每升高1个单位,诊断年龄提前0.36年(β=-0.36,95%CI -0.56至-0.16,P=4.0×10-4)。
  • GRS最高5%与最低5%相比,平均诊断年龄早5.2年(61.4[12.7]岁 vs 66.6[12.9]岁,P=5.0×10-4)。

临床怎么用

  • 作者认为包含POAG相关遗传变异的GRS可能有助于识别有早发风险的患者,从而影响筛查和治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Genetic variants associated with primary open-angle glaucoma (POAG) are known to influence disease risk. However, the clinical effect of associated variants individually or in aggregate is not known. Genetic risk scores (GRS) examine the cumulative genetic load by combining individual genetic variants into a single measure, which is assumed to have a larger effect and increased power to detect relevant disease-related associations. OBJECTIVE: To investigate if a GRS that comprised 12 POAG genetic risk variants is associated with age at disease diagnosis. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study included individuals with POAG and controls from the Glaucoma Genes and Environment (GLAUGEN) study and the National Eye Institute Glaucoma Human Genetics Collaboration (NEIGHBOR) study. A GRS was formulated using 12 variants known to be associated with POAG, and the alleles associated with increasing risk of POAG were aligned in the case-control sets. In case-only analyses, the association of the GRS with age at diagnosis was analyzed as an estimate of disease onset. Results from cohort-specific analyses were combined with meta-analysis. Data collection started in August 2012 for the NEIGHBOR cohort and in July 2008 for the GLAUGEN cohort and were analyzed starting in March 2018. MAIN OUTCOMES AND MEASURES: Association of a 12 single-nucleotide polymorphism POAG GRS with age at diagnosis in individuals with POAG using linear regression. RESULTS: The GLAUGEN study included 976 individuals with POAG and 1140 controls. The NEIGHBOR study included 2132 individuals with POAG and 2290 controls. For individuals with POAG, the mean (SD) age at diagnosis was 63.6 (9.8) years in the GLAUGEN cohort and 66.0 (13.7) years in the NEIGHBOR cohort. For controls, the mean (SD) age at enrollment was 65.5 (9.2) years in the GLAUGEN cohort and 68.9 (11.4) years in the NEIGHBOR cohort. All study participants were European white. The GRS was strongly associated with POAG risk in case-control analysis (odds ratio per 1-point increase in score = 1.24; 95% CI, 1.21-1.27; P = 3.4 × 10-66). In case-only analyses, each higher GRS unit was associated with a 0.36-year earlier age at diagnosis (β = -0.36; 95% CI, -0.56 to -0.16; P = 4.0 × 10-4). Individuals in the top 5% of the GRS had a mean (SD) age at diagnosis of 5.2 (12.8) years earlier than those in the bottom 5% GRS (61.4 [12.7] vs 66.6 [12.9] years; P = 5.0 × 10-4). CONCLUSIONS AND RELEVANCE: A higher dose of POAG risk alleles was associated with an earlier age at glaucoma diagnosis. On average, individuals with POAG with the highest GRS had 5.2-year earlier age at diagnosis of disease. These results suggest that a GRS that comprised genetic variants associated with POAG could help identify patients with risk of earlier disease onset impacting screening and therapeutic strategies.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fan BJ, Bailey JC, Igo RP, et al. Association of a Primary Open-Angle Glaucoma Genetic Risk Score With Earlier Age at Diagnosis. JAMA Ophthalmol. 2019. PMID: 31436842. doi:10.1001/jamaophthalmol.2019.3109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。